Education
About Us
Working with TipRanks
Follow Us
Co-Diagnostics Inc (CODX)
NASDAQ:CODX
CODX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.28 - $2.23
Previous CloseN/A
Volume146.43K
Average Volume (3M)243.08K
Market Cap
$10.74M
Enterprise Value-$2.81M
Total Cash (Recent Filing)$950.24K
Total Debt (Recent Filing)$1.91M
Price to Earnings (P/E)―
Beta1.63
Next Earnings
May 08, 2025EPS Estimate
-0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.22
Shares Outstanding33,572,643
10 Day Avg. Volume312,145
30 Day Avg. Volume243,076
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.01
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.26
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-1.07
Enterprise Value/Ebitda0.07
Forecast
1Y Price Target
$1.00Price Target Upside212.50% Upside
Rating ConsensusHold
Number of Analyst Covering1
---
Co-Diagnostics News
PremiumCompany Announcements
Co-Diagnostics Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Co-Diagnostics Reports 2024 Financial Results and Strategic Progress
---
Bulls Say, Bears Say
Bulls Say
Infrastructure ExpansionA new manufacturing facility has been inaugurated in South Salt Lake to manufacture components for the new Co-Dx PCR platform.
Product DevelopmentThe company plans to submit a new iteration of the Co-Dx PCR COVID-19 test for 510(k) OTC clearance, which could enhance the test and streamline operational and manufacturing processes.
Bears Say
Financial PerformanceRevenue for full-year 2024 was $3.9M, representing a 43% year-over-year decline.
Financial PositionThe price objective decreased to $1 due to a higher number of shares outstanding and a lower cash position.
Regulatory ChallengesThe company withdrew its 510(k) application for its Co-Dx PCR COVID-19 test due to concerns about shelf-life stability.
---
Ownership Overview
5.09% Insiders
7.38% Mutual Funds
5.09% Other Institutional Investors
76.83% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CODX FAQ
What was Co-Diagnostics Inc’s price range in the past 12 months?
Co-Diagnostics Inc lowest stock price was $0.28 and its highest was $2.23 in the past 12 months.
What is Co-Diagnostics Inc’s market cap?
Co-Diagnostics Inc’s market cap is $10.74M.
When is Co-Diagnostics Inc’s upcoming earnings report date?
Co-Diagnostics Inc’s upcoming earnings report date is May 08, 2025 which is in 39 days.
How were Co-Diagnostics Inc’s earnings last quarter?
Co-Diagnostics Inc released its earnings results on Mar 27, 2025. The company reported -$0.36 earnings per share for the quarter, missing the consensus estimate of -$0.34 by -$0.02.
Is Co-Diagnostics Inc overvalued?
According to Wall Street analysts Co-Diagnostics Inc’s price is currently Undervalued.
Does Co-Diagnostics Inc pay dividends?
Co-Diagnostics Inc does not currently pay dividends.
What is Co-Diagnostics Inc’s EPS estimate?
Co-Diagnostics Inc’s EPS estimate is -0.33.
How many shares outstanding does Co-Diagnostics Inc have?
Co-Diagnostics Inc has 33,572,643 shares outstanding.
What happened to Co-Diagnostics Inc’s price movement after its last earnings report?
Co-Diagnostics Inc reported an EPS of -$0.36 in its last earnings report, missing expectations of -$0.34. Following the earnings report the stock price went down -17.949%.
Which hedge fund is a major shareholder of Co-Diagnostics Inc?
Currently, no hedge funds are holding shares in CODX
---
Co-Diagnostics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1.00 (212.50% Upside)
$1.00 (212.50% Upside)
Hedge Fund Trend
Decreased
By 36.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 9.9%
Last 30 Days ▼ 9.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-71.42%
12-Months-Change
Fundamentals
Return on Equity
-53.65%
Trailing 12-Months
Asset Growth
-31.31%
Trailing 12-Months
Company Description
Co-Diagnostics Inc
Co-Diagnostics, Inc. (CODX) is a molecular diagnostics company that specializes in the development, manufacturing, and marketing of advanced diagnostic technology. The company's core products include diagnostic tests and reagents used for the detection of infectious diseases, genetic disorders, and other health conditions. Co-Diagnostics leverages its patented CoPrimer technology to offer innovative solutions in the healthcare and diagnostics sectors, aiming to enhance the accuracy and efficiency of molecular testing.
---
CODX Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant advancements in the Co-Dx PCR platform and test pipeline, supported by external organizations, and new manufacturing capabilities. However, financial challenges were evident with decreased revenue and increased legal expenses, along with a setback in regulatory progress for the COVID-19 test.Read More>---
CODX Stock 12 Month Forecast
Average Price Target
$1.00
▲(212.50% Upside)
Technical Analysis
---